Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermal Effects of Local Anesthetics
NCT04761887Phase 1Withdrawn
- Start
- Dec 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Time to block of pain and thermosensory perception at 35 minutes. Planned start Dec 2022; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04761887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04761887.